A Study to Evaluate the Safety and Tolerability of Cendakimab in Chinese Healthy Participants
Clinical trial NCT05638282 · COMPLETED
Trial details
- NCT number
- NCT05638282
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-15
- Primary completion
- 2023-06-27
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.